The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 2000;343(8):591.

Editorial
PreviousPrevious
Volume 342:1904-1907 June 22, 2000 Number 25
NextNext

The Acute Chest Syndrome of Sickle Cell Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-Related Article
 by Vichinsky, E. P.
-PubMed Citation
It has become a cliché to say that sickle cell anemia is the first "molecular disease."1 The substitution of valine for glycine in ß-globin has been known as the cause of sickle cell anemia since 1957.2 That this specific knowledge has not resulted in a rationally designed, specific cure remains a disappointment. What is not disappointing is that the study of sickle hemoglobin and sickle red cells has provided important information about the pathophysiology of the disease, and this information forms the basis for rationally designed clinical care.

The polymerization of sickle hemoglobin is central to the disorder (Figure . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.